Impact Of Trips In India: An Access to Medicines Perspective

Hardcover | November 15, 2010

byPrabodh Malhotra

not yet rated|write a review
In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India’s entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable

Pricing and Purchase Info

$162.50

In stock online
Ships free on orders over $25

From the Publisher

In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India’s entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable

PRABODH MALHOTRA was born and brought up in India but has been living in Australia since 1980. Thus, he understands both systems. He has taught at a number of universities in Australia. Prabodh has PhD in Economics and Masters in International Business and has published conference papers, journal articles and government reports in the...
Format:HardcoverDimensions:288 pages, 8.78 × 5.57 × 1.02 inPublished:November 15, 2010Publisher:Palgrave MacmillanLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0230272789

ISBN - 13:9780230272781

Customer Reviews of Impact Of Trips In India: An Access to Medicines Perspective

Reviews

Extra Content

Table of Contents

Foreword
Acknowledgments
Introduction
PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES
The World Trade Organization and the TRIPS Agreement
The Global Pharmaceutical Industry and Developing New Drugs
PART II: ACCESS TO MEDICINES IN INDIA
Development of India’s Pharmaceutical Industry
TRIPS and the Indian Patents Regime
Price Controls and Drug Affordability in India: Policy Options
Health Insurance in India
Broadening the Access to Medicines and Healthcare in India
PART III: GLOBAL PERSPECTIVE
Is TRIPS Appropriate for Developing Countries?
Which Way Ahead?
Final Conclusions
References